Related Experiment Video
Updated: Jul 16, 2026

Generating Transposon Insertion Libraries in Gram-Negative Bacteria for High-Throughput Sequencing
Published on: July 7, 2020
High-level gentamicin resistance mediated by a Tn4001-like transposon in seven nonclonal hospital isolates of
Viola C Y Chow1, Peter M Hawkey, Edward W C Chan
1Department of Microbiology, The Chinese University of Hong Kong, The Prince of Wales Hospital, 30-32 Ngan Shing St., Shatin, New Territories, Hong Kong SAR, China. violachow@cuhk.edu.hk
Abstract:
We report on the first occurrence of high-level gentamicin resistance (MICs > or = 512 microg/ml) in seven clinical isolates of Streptococcus pasteurianus from Hong Kong. These seven isolates were confirmed to be the species S. pasteurianus on the basis of nucleotide sequencing of the superoxide dismutase (sodA) gene. Epidemiological data as well as the results of pulse-field gel electrophoresis analysis suggested that the seven S. pasteurianus isolates did not belong to the same clone. Molecular characterization showed that they carried a chromosomal, transposon-borne resistance gene [aac(6')Ie-aph(2'')Ia] which was known to encode a bifunctional aminoglycoside-modifying enzyme. The genetic arrangement of this transposon was similar to that of Tn4001, a transposon previously recovered from Staphylococcus aureus and other gram-positive isolates. Genetic linkage with other resistance elements, such as the ermB gene for erythromycin resistance, was not evident. On the basis of these findings, we suggest that routine screening for high-level gentamicin resistance should be recommended for all clinically significant blood culture isolates. This is to avoid the inadvertent use of short-course combination therapy with penicillin and gentamicin, which may lead to the failure of treatment for endocarditis, the selection of drug-resistant Streptococcus pasteurianus and other gram-positive organisms, as well as the unnecessary usage of gentamicin, a drug with potential toxicity.
Insights
High-level gentamicin resistance was found in Streptococcus pasteurianus clinical isolates in Hong Kong. This resistance is linked to a specific gene, necessitating routine screening to prevent treatment failures and further resistance development.
Area of Science:
- Microbiology
- Genetics
- Infectious Diseases
Background:
- High-level gentamicin resistance (HLGR) is a significant concern in treating Gram-positive bacterial infections.
- Streptococcus pasteurianus is an emerging pathogen, and its antimicrobial resistance patterns require investigation.
Purpose of the Study:
- To report the first occurrence of HLGR in clinical isolates of Streptococcus pasteurianus.
- To characterize the genetic basis and epidemiological relatedness of these resistant isolates.
Main Methods:
- Species identification using sodA gene sequencing.
- Molecular typing via pulse-field gel electrophoresis (PFGE).
- Characterization of resistance genes and transposon structures.
Main Results:
- Seven clinical isolates of Streptococcus pasteurianus from Hong Kong exhibited HLGR (MICs ≥ 512 μg/ml).
- Isolates were confirmed as S. pasteurianus via sodA gene sequencing.
- PFGE indicated isolates were not clonally related.
- A chromosomal, transposon-borne gene [aac(6')Ie-aph(2'')Ia] encoding a bifunctional aminoglycoside-modifying enzyme was identified.
- The transposon structure was similar to Tn4001.
Conclusions:
- Routine screening for HLGR in clinically significant blood culture isolates is recommended.
- This screening can prevent treatment failures in conditions like endocarditis.
- It also helps avoid the selection of resistant strains and unnecessary gentamicin use.
More Related Videos
Related Concept Videos
Mechanism of Antibiotic Resistance in MRSA
Development of Antibiotic Resistance
Clinical Significance of Antibiotic Resistance
Transposons
Antibiotic Selection
Transduction

